The relationship between pneumococcal serotypes and antibiotic resistance

Pediatria Polska

Volumn 88, Issue 6, 2013, Pages

  Song, Jae Hoon ^a,b   Dagan, Ron ^c   Klugman, Keith P ^d,e   Fritzell, Bernard ^f  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f PFIZER INC   (United States)

Author keywords

Antibiotic resistance; PCV7; Pneumococcal; Pneumococcal conjugate vaccine; Pneumococcal serotypes; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; CLONAL COMPLEX; CLONE; DISEASE SURVEILLANCE; GENOTYPE; HEALTH PROGRAM; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRESSURE; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84888335146     PISSN: 00313939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pepo.2013.09.007     Document Type: Review

References (139)

1. R.R. Reinert, M. van der Linden, I. Seegmüller, A. Al-Lahham, A. Siedler, and B. Weissmann Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany Clin Microbiol Infect 13 2007 363 368
2. J.H. Song, S.I. Jung, K.S. Ko, N.Y. Kim, J.S. Son, and H.H. Chang High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ASNORP study) Antimicrob Agents Chemother 48 2004 2101 2107
3. M. Imöhl, R.R. Reinert, and M. van der Linden Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states Int J Med Microbiol 300 2010 237 247
4. A. Fenoll, J.J. Granizo, L. Aguilar, M.J. Giménez, L. Aragoneses-Fenoll, and G. Hanquet Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007 J Clin Microbiol 47 2009 1012 1020
5. D.J. Farrell, K.P. Klugman, and M. Pichichero Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States Pediatr Infect Dis J 26 2007 123 128
6. R. Dagan, and K.P. Klugman Impact of conjugate pneumococcal vaccines on antibiotic resistance Lancet Infect Dis 8 2008 785 795
7. D. Greenberg, N. Givon-Lavi, A.Z. Sharf, D. Vardy, and R. Dagan The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children Pediatr Infect Dis J 27 2008 776 782
8. R. Cohen, C. Levy, F. de La Rocque, N. Gelbert, A. Wollner, and B. Fritzell Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media Pediatr Infect Dis J 25 2006 1001 1007
9. I. Katsarolis, G. Poulakou, A. Analitis, I. Matthaiopoulou, E. Roilides, and C. Antachopoulos Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece BMC Infect Dis 9 2009 120
10. N. van de Sande-Bruinsma, H. Grundmann, D. Verloo, E. Tiemersma, J. Monen, and H. Goossens Antimicrobial drug use and resistance in Europe Emerg Infect Dis 14 2008 1722 1730
11. F. Rodrigues, S. Nunes, Sá-Leão, G. Conçalves, L. Lemos, and H. de Lencastre Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine Microbial Drug Resist 15 2009 269 277
12. C.M. Franco, A.L. Andrade, J.G. Andrade, S. Almeida e Silva, C.R. Oliveira, and F.C. Pimenta Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day-care centers in Brazil Pediatr Infect Dis J 29 2010 77 79
13. J. Van Eldere, R.M. Mera, L.A. Miller, J.A. Poupard, and H. Amrine-Madsen Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location Antimicrob Agents Chemother 51 2007 3491 3497
14. R. Cohen, C. Levy, E. Bonnet, S. Grondin, V. Desvignes, and A. Lecuyer Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France Vaccine 28 2010 6114 6121
15. J.A. Finkelstein, S.S. Huang, J. Daniel, S.L. Rifas-Shiman, K. Kleinman, and D. Goldmann Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample Pediatrics 112 2003 862 869
16. R. Cohen, C. Levy, E. Bonnet, S. Grondin, V. Desvignes, and A. Lecuyer Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France Vaccine 28 2010 6114 6121
17. R. Dagan, N. Givon-Lavi, O. Zamir, and D. Fraser Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers Pediatr Infect Dis J 22 2003 532 540
18. N. Frazão, A. Brito-Avô, C. Simas, J. Saldanha, R. Mato, and S. Nunes Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon Pediatr Infect Dis J 24 2005 243 252
19. I. de Miguel-Martínez, A. Ramos-Macías, and S. Borkoski Barreiro [Efficacy of heptavalent pneumococcal conjugate vaccine in children with cochlear implant] Acta Otorrinolaringol Esp 59 2008 2 5 [Article in Spanish]
20. N. Mbelle, R.E. Huebner, A.D. Wasas, A. Kimura, I. Chang, and K.P. Klugman Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine J Infect Dis 180 1999 1171 1176
21. R. Mera, L.A. Miller, T.R. Fritsche, and R.N. Jones Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine Microb Drug Resist 14 2008 101 107
22. S.I. Aguiar, I. Serrano, F.R. Pinto, J. Melo-Cristino, M. Ramirez Portuguese Surveillance Group for the Study of Respiratory Pathogens Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine Clin Microbiol Infect 14 2008 835 843
23. K.L. O'Brien, and R. Dagan The potential indirect effect of conjugate pneumococcal vaccines Vaccine 21 2003 1815 1825
24. T. Pilishvili, C. Lexau, M.M. Farley, J. Hadler, L.H. Harrison, and N.M. Bennett Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine J Infect Dis 201 2010 32 41
25. J.A. Bettinger, D.W. Scheifele, J.D. Kellner, S.A. Halperin, W. Vaudry, and B. Law The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007 Vaccine 28 2010 2130 2136
26. A. Lepoutre, E. Varon, S. Georges, L. Gutmann, and D. Lévy-Bruhl Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006 Euro Surveill 13 2008 18962
27. Z.B. Harboe, P. Valentiner-Branth, T.L. Benfield, J.J. Christensen, P.H. Andersen, and M. Howitz Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme Vaccine 28 2010 2642 2647
28. J. Aristegui, E. Bernaola, I. Pocheville, C. García, L. Arranz, and G. Durán Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine Eur J Clin Microbiol Infect Dis 26 2007 303 310
29. D.F. Vestrheim, E.A. Høiby, M.R. Bergsaker, K. Rønning, I.S. Aaberge, and D.A. Caugant Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule Vaccine 28 2010 2214 2221
30. M.H. Kyaw, R. Lynfield, W. Schaffner, A.S. Craig, J. Hadler, and A. Reingold Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae N Engl J Med 354 2006 1455 1463
31. B. Beall, M.C. McEllistrem, R.E. Gertz Jr., S. Wedel, D.J. Boxrud, and A.L. Gonzalez Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002 J Clin Microbiol 44 2006 999 1017
32. S.I. Pelton, H. Huot, J.A. Finkelstein, C.J. Bishop, K.K. Hsu, and J. Kellenberg Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine Pediatr Infect Dis J 26 2007 468 472
33. R. Reinert, M.R. Jacobs, and S.L. Kaplan Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development Vaccine 28 2010 4249 4259
34. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement [document M100-S18] 2008 National Committee for Clinical Laboratory Standards Wayne, PA
35. M.P. Weinstein, K.P. Klugman, and R.N. Jones Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance Clin Infect Dis 48 2009 1596 1600
36. Centers for Disease Control and Prevention (CDC) Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae - United States, 2006-2007 MMWR Morb Mortal Wkly Rep 57 2008 1353 1355
37. M.A. Borg, E. Tiemersma, E. Scicluna, N. van de Sande-Bruinsma, M. de Kraker, and J. Monen Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region Clin Microbiol Infect 15 2009 232 237
38. E. Castañeda, C.I. Agudelo, M. Regueira, A. Corso, M.C. Brandileone, and A.P. Brandão Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005 Pediatr Infect Dis J 28 2009 e265 e270
39. S. Mudhune, M. Wamae Network Surveillance for Pneumococcal Disease in the East African Region Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region Clin Infect Dis 48 Suppl 2 2009 S147 S152
40. D.J. Farrell, D. Felmingham, J. Shackcloth, L. Williams, K. Maher, and R. Hope Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007 J Antimicrob Chemother 62 Suppl 2 2008 ii87 ii95
41. R. Reynolds, R. Hope on behalf of the BSAC Working Parties on Resistance Surveillance Survey, laboratory, and statistical methods for the BSAC Resistance Surveillance Programmes J Antimicrob Chemother 62 Suppl 2 2008 ii15 ii28
42. Z.B. Harboe, T.L. Benfield, P. Valentiner-Branth, T. Hjuler, L. Lambertsen, and M. Kaltoft Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades Clin Infect Dis 50 2010 329 337
43. C. Ardanuy, D. Rolo, A. Fenoll, D. Tarrago, L. Calatayud, and J. Liñares Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain J Antimicrob Chemother 64 2009 507 510
44. J. Oteo, E. Lázaro, F.J. de Abajo, F. Baquero, J. Campos and Spanish Member of the European Antimicrobial Resistance Surveillance System Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates J Clin Microbiol 42 2004 5571 5577
45. P. Nilsson, and M.H. Laurell A 10-year follow-up study of penicillin-non-susceptible S. pneumoniae during an intervention programme in Malmö, Sweden Scand J Infect Dis 38 2006 838 844
46. D.F. Vestrheim, E.A. Høiby, I.S. Aaberge, and D.A. Caugant Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway Clin Vaccine Immunol 17 2010 325 334
47. G.J. Tyrrell, M. Lovgren, N. Chui, J. Minion, S. Garg, and J.D. Kellner Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006 Vaccine 27 2009 3553 3560
48. S.G. Jenkins, and D.J. Farrell Increase in pneumococcus macrolide resistance, United States Emerg Infect Dis 15 2009 1260 1264
49. N. Wolter, A. von Gottberg, M. du Plessis, L. de Gouveia, K.P. Klugman Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005 Int J Antimicrob Agents 32 2008 62 67
50. J.H. Song, H.H. Chang, J.Y. Suh, K.S. Ko, S.I. Jung, and W.S. Oh Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP) J Antimicrobial Chemother 53 2004 457 463
51. M. Imöhl, R.R. Reinert, C. Mutscher, and M. van der Linden Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008 BMC Microbiol 10 2010 299
52. D.J. Farrell, S.G. Jenkins, S.D. Brown, M. Patel, B.S. Lavin, and K.P. Klugman Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance Emerg Infect Dis 11 2005 851 858
53. K.L. Nielsen, A.M. Hammerum, L.M. Lambertsen, C.H. Lester, M. Arpi, and J.D. Knudsen Characterization and transfer studies of macrolide resistance genes in Streptococcus pneumoniae from Denmark Scand J Infect Dis 42 2010 586 593
54. M.K. Sogstad, P. Littauer, I.S. Aaberge, D.A. Caugant, and A. Høiby Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides Microb Drug Resist 13 2007 29 36
55. S.I. Fouda, A.A. Kadry, and A.M. Shibl B-lactam and macrolide resistance and serotype distribution among Streptococcus pneumoniae isolates from Saudi Arabia J Chemother 28 2004 517 523
56. X. Xu, L. Cai, M. Xiao, F. Kong, S. Oftadeh, and F. Zhou Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates Antimicrob Agents Chemother 54 2010 1152 1159
57. M.W. Pletz, L. McGee, J. Jorgensen, B. Beall, R.R. Facklam, and C.G. Whitney Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine Antimicrob Agents Chemother 48 2004 3491 3497
58. R.R. Reinert, S. Reinert, M. van der Linden, M.Y. Cil, A. Al-Lahham, and P. Appelbaum Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003 Antimicrob Agents Chemother 49 2005 2903 2913
59. H.J. Adam, D.J. Hoban, A.S. Gin, and G.G. Zhanel Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006 Int J Antimicrob Agents 34 2009 82 85
60. H.J. Adam, K.N. Schurek, K.A. Nichol, C.J. Hoban, T.J. Baudry, and N.M. Laing Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005 Antimicrob Agents Chemother 51 2007 198 207
61. T.A. Davies, Y.C. Yee, K. Bush, D. Sahm, A. Evangelista, and R. Goldschmidt Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae Microb Drug Resist 14 2008 187 196
62. M. Ip, S.S. Chau, F. Chi, E.S. Cheuk, H. Ma, and R.W. Lai Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin- susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005 Antimicrob Agents Chemother 51 2007 2192 2194
63. M. Ip, E.A. Nelson, E.S. Cheuk, R.Y. Sung, A. Li, and H. Ma Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong J Clin Microbiol 45 2007 1969 1971
64. P.L. Ho, T.L. Que, S.S. Chiu, R.W. Yung, T.K. Ng, and D.N. Tsang Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001 Emerg Infect Dis 10 2004 1250 1257
65. A. von Gottberg, K.P. Klugman, C. Cohen, N. Wolter, L. de Gouveia, and M. du Plessis Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study Lancet 371 2008 1108 1113
66. N. Wolter, M. du Plessis, A. von Gottberg, L. de Gouveia, and K.P. Klugman Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa J Clin Microbiol 47 2009 1319 1324
67. T.L. Lauderdale, M.M. Wagener, H.M. Lin, I.F. Huang, W.Y. Lee, and K.S. Hseih Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates Diagn Microbiol Infect Dis 56 2006 421 426
68. S. Lee, K. Lee, Y. Kang, and S. Bae Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005 Microb Drug Resist 16 2010 135 142
69. M.R. Jacobs, C.E. Good, B. Beall, S. Bajaksouzian, A.R. Windau, and C.G. Whitney Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience J Clin Microbiol 46 2008 982 990
70. Q. Xu, M.E. Pichichero, J.R. Casey, and M. Zeng Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children Emerg Infect Dis 15 2009 547 551
71. M.R. Moore, R.E. Gertz Jr., R.L. Woodbury, G.A. Barkocy-Gallagher, W. Schaffner, and C. Lexau Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005 J Infect Dis 197 2008 1016 1027
72. R. Pai, M.R. Moore, T. Pilishvili, R.E. Gertz, C.G. Whitney, and B. Beall Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States J Infect Dis 192 2005 1988 1995
73. B.W. Beall, R.E. Gertz, R.L. Hulkower, C.G. Whitney, M.R. Moore, and A.B. Brueggemann Shifting genetic structure of invasive serotype 19A pneumococci in the United States J Infect Dis 203 2011 1360 1368
74. D.R. Pillai, D. Shahinas, A. Buzina, R.A. Pollock, R. Lau, and K. Khairnar Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae BMC Genomics 10 2009 642
75. S.L. Bronzwaer, O. Cars, U. Buchholz, S. Mölstad, W. Goettsch, and I.K. Veldhuijzen A European Study on the relationship between antimicrobial use and antimicrobial resistance Emerg Infect Dis 8 2002 278 282
76. H. Goossens, M. Ferech, R. Vander Stichele, M. Elseviers ESAC Project Group Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 2005 579 587
77. R. Dias, and M. Caniça Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal Epidemiol Infect 136 2008 928 939
78. R. Dias, and M. Caniça Emergence of invasive erythromycin- resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14 J Antimicrob Chemother 54 2004 1035 1039
79. L.A. Hicks, Y.W. Chien, T.H. Taylor Jr., M. Haber, K.P. Klugman Active Bacterial Core Surveillance (ABCs) Team Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003 Clin Infect Dis 53 2011 631 639
80. R. Dagan, G. Barkai, N. Givon-Lavi, A.Z. Sharf, D. Vardy, and T. Cohen Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis 197 2008 1094 1102
81. R. Dagan, N. Givon-Lavi, E. Leibovitz, D. Greenberg, and N. Porat Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population J Infect Dis 199 2009 776 785
82. N. Porat, U. Amit, N. Givon-Lavi, E. Leibovitz, and R. Dagan Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel Pediatr Infect Dis J 29 2010 126 130
83. O.G. Vanderkooi, D.E. Low, K. Green, J.E. Powis, A. McGeer Toronto Invasive Bacterial Disease Network Predicting antimicrobial resistance in invasive pneumococcal infections Clin Infect Dis 40 2005 1288 1297
84. A.B. Brueggemann, T.E. Peto, D.W. Crook, J.C. Butler, K.G. Kristinsson, and B.G. Spratt Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children J Infect Dis 190 2004 1203 1211
85. K. Sjöström, C. Spindler, A. Ortqvist, M. Kalin, A. Sandgren, and S. Kühlmann-Berenzon Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen Clin Infect Dis 42 2006 451 459
86. D.S. Shouval, D. Greenberg, N. Givon-Lavi, N. Porat, and R. Dagan Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media, and acute conjunctivitis Pediatr Infect Dis J 25 2006 602 607
87. L. Högberg, P. Geli, H. Ringberg, E. Melander, M. Lipsitch, and K. Ekdahl Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci J Clin Microbiol 45 2007 948 952
88. B. Henriques-Normark, C. Blomberg, J. Dagerhamn, P. Bättig, and S. Normark The rise and fall of bacterial clones: Streptococcus pneumoniae Nat Rev Microbiol 6 2008 827 837
89. T.J. Coffey, C.G. Dowson, M. Daniels, J. Zhou, C. Martin, and B.G. Spratt Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae Mol Microbiol 5 1991 2255 2260
90. S.D. Brugger, P. Frey, S. Aebi, J. Hinds, and K. Mühlemann Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine PLoS One 5 2010 e11638
91. N. Chiba, M. Morozumi, K. Sunaoshi, S. Takahashi, M. Takano, and T. Komori Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan Epidemiol Infect 138 2010 61 68
92. L.A. Hicks, L.H. Harrison, B. Flannery, J.L. Hadler, W. Schaffner, and A.S. Craig Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004 J Infect Dis 196 2007 1346 1354
93. Centers for Disease Control and Prevention (CDC) Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae - Massachusetts, 2001-2006 MMWR Morb Mortal Wkly Rep 56 2007 1077 1080
94. R.E. Gertz Jr., Z. Li, F.C. Pimenta, D. Jackson, B.A. Juni, and R. Lynfield Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era J Infect Dis 201 2010 770 775
95. M. Imöhl, R.R. Reinert, and M. van der Linden Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008 Int J Med Microbiol 300 2010 324 330
96. L. Dortet, M.C. Ploy, C. Poyart, J. Raymond ORP Ile de France Ouest Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology Diagn Microbiol Infect Dis 65 2009 49 57
97. A. Fenoll, L. Aguilar, M.J. Giménez, M.D. Vicioso, O. Robledo, and J.J. Granizo Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine Antimicrob Agents Chemother 54 2010 2696 2698
98. C. Muñoz-Almagro, C. Esteva, M.F. de Sevilla, L. Selva, A. Gene, and R. Pallares Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona J Infect 59 2009 75 82
99. L.M. Hampton, M.M. Farley, W. Schaffner, A. Thomas, A. Reingold, and L.H. Harrison Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines J Infect Dis 2011 doi:1093/infdis/jir755
100. Y.Y. Chen, S.M. Yao, C.Y. Chou, Y.C. Chang, P.W. Shen, and C.T. Huang Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003 J Med Microbiol 55 2006 1109 1114
101. L. Zhou, S.J. Yu, W. Gao, K.H. Yao, A.D. Shen, and Y.H. Yang Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010 Vaccine 29 2011 7704 7710
102. O. de, A.P. Menezes, L.C. Campos, M.S. dos Santos, J. Azevedo, R.C. Dos Santos, M. Carvalho, and G. da Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007 Vaccine 29 2011 1139 1144
103. M. Watson, M. Brett, M. Brown, M.G. Stewart, and S. Warren Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia J Med Microbiol 56 2007 819 823
104. Y.C. Hsieh, P.Y. Lin, C.H. Chiu, Y.C. Huang, K.Y. Chang, and C.H. Liao National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential Vaccine 27 2009 5513 5518
105. N. Porat, C. Soley, M.M. Marengolciene, D. Greenberg, N. Givon-Lavi, and R. Trefler An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania Pediatr Infect Dis J 27 2008 709 712
106. A.L. Andrade, C.M. Franco, J. Lamaro-Cardoso, M.C. André, L.L. Oliveira, and A. Kipnis Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants J Infect 61 2010 314 322
107. E.H. Choi, S.H. Kim, B.W. Eun, S.J. Kim, N.H. Kim, and J. Lee Streptococcus pneumoniae serotype 19A in children, South Korea Emerg Infect Dis 14 2008 275 281
108. J. Shin, J.Y. Baek, S.H. Kim, J.H. Song, and K.S. Ko Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries J Antimicrob Chemother 66 2011 1001 1004
109. J.M. Jefferies, A.J. Smith, G.F. Edwards, J. McMenamin, T.J. Mitchell, and S.C. Clarke Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine J Clin Microbiol 48 2010 87 96
110. S.R. Williams, P.J. Mernagh, M.H. Lee, and J.T. Tan Changing epidemiology of invasive pneumococcal disease in Australian children after introduction of a 7-valent pneumococcal conjugate vaccine Med J Aust 194 2011 116 120
111. S.S. Huang, R. Platt, S.L. Rifas-Shiman, S.I. Pelton, D. Goldmann, and J.A. Finkelstein Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004 Pediatrics 116 2005 e408 e413
112. S.Y. Park, M.R. Moore, D.L. Bruden, T.B. Hyde, A.L. Reasonover, and M. Harker-Jones Impact of conjugate vaccine on transmission of antimicrobial- resistant Streptococcus pneumoniae among Alaskan children Pediatr Infect Dis J 27 2008 335 340
113. S.S. Huang, V.L. Hinrichsen, A.E. Stevenson, S.L. Rifas-Shiman, K. Kleinman, and S.I. Pelton Continued impact of pneumococcal conjugate vaccine on carriage in young children Pediatrics 124 2009 e1 e11
114. S.S. Richter, K.P. Heilmann, C.L. Dohrn, F. Riahi, S.E. Beekmann, and G.V. Doern Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005 Clin Infect Dis 48 2009 e23 e33
115. K.K. Hsu, K.M. Shea, A.E. Stevenson, S.I. Pelton Massachusetts Department of Public Health Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007 Pediatr Infect Dis J 29 2010 289 293
116. D.S. Stephens, S.M. Zughaier, C.G. Whitney, W.S. Baughman, L. Barker, and K. Gay Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment Lancet 365 2005 855 863
117. B. Fireman, S.B. Black, H.R. Shinefield, J. Lee, E. Lewis, and P. Ray Impact of the pneumococcal conjugate vaccine on otitis media Pediatr Infect Dis J 22 2003 10 16
118. R. Dagan, M. Sikuler-Cohen, O. Zamir, J. Janco, N. Givon-Lavi, and D. Fraser Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees Pediatr Infect Dis J 20 2001 951 958
119. D.M. Weinberger, K. Trzcínski, Y.J. Lu, D. Bogaert, A. Brandes, and J. Galagan Pneumococcal capsular polysaccharide structure predicts serotype prevalence PLoS Pathog 5 2009 e1000476
120. K. Ampofo, A.T. Pavia, C. Stockmann, A.L. Hersh, J.M. Bender, and A.J. Blaschke The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the PCV7 era Pediatr Infect Dis J 2011 10.1097/IFN.0b013e31823dcc72
121. B.A. Kendall, K.K. Dascomb, R.R. Mehta, E.O. Mason, K. Ampofo, and D.J. Pombo Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era Vaccine 29 2011 9123 9126
122. N. Grall, O. Hurmic, M. Al Nakib, M. Longo, C. Poyart, and M.C. Ploy Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine Eur J Clin Microbiol Infect Dis 30 2011 1511 1519
123. S.L. Kaplan, W.J. Barson, P.L. Lin, S.H. Stovall, J.S. Bradley, and T.Q. Tan Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children Pediatrics 125 2010 429 436
124. A.F. Messina, K. Katz-Gaynor, T. Barton, N. Ahmad, F. Ghaffar, and D. Rasko Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005 Pediatr Infect Dis J 26 2007 461 467
125. M.E. Pichichero, and J.R. Casey Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children JAMA 298 2007 1772 1778
126. F. Ansaldi, P. Canepa, D. de Florentiis, R. Bandettini, P. Durando, and G. Icardi Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine Clin Vaccine Immunol 18 2011 343 345
127. C. Techasaensiri, A.F. Messina, K. Katz, N. Ahmad, R. Huang, and G.H. McCracken Jr. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas Pediatr Infect Dis J 29 2010 294 300
128. W.P. Hanage, C.J. Bishop, S.S. Huang, A.E. Stevenson, S.I. Pelton, and M. Lipsitch Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching Pediatr Infect Dis J 30 2011 302 308
129. A. Vergison, R. Dagan, A. Arguedas, J. Bonhoeffer, R. Cohen, and I. Dhooge Otitis media and its consequences: beyond the earache Lancet Infect Dis 10 2010 195 203
130. L. Temime, D. Guillemot, and P.Y. Boëlle Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance Antimicrob Agents Chemother 48 2004 2206 2213
131. T.W. Hennessy, K.M. Petersen, D. Bruden, A.J. Parkinson, D. Hurlburt, and M. Getty Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska Clin Infect Dis 34 2002 1543 1550
132. N. Bermal, L. Szenborn, A. Chrobot, E. Alberto, P. Lommel, and S. Gatchalian The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity Pediatr Infect Dis J 28 4 Suppl 2009 S89 S96
133. B. Chevallier, T. Vesikari, J. Brzostek, M. Knuf, N. Bermal, and J. Aristegui Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines Pediatr Infect Dis J 28 4 Suppl 2009 S109 S118
134. T. Vesikari, J. Wysocki, B. Chevallier, A. Karvonen, H. Czajka, and J.P. Arsène Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine Pediatr Infect Dis J 28 4 Suppl 2009 S66 S76
135. K.A. Bryant, S.L. Block, S.A. Baker, W.C. Gruber, D.A. Scott PCV13 Infant Study Group Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine Pediatrics 125 2010 866 875
136. S. Esposito, S. Tansey, A. Thompson, A. Razmpour, J. Liang, and T.R. Jones Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine compared to 7-valent pneumococcal conjugate vaccine given as a 3-dose series with routine vaccines in healthy infants and toddlers Clin Vaccine Immunol 17 2010 1017 1026
137. D.M. Kieninger, K. Kueper, K. Steul, C. Juergens, N. Ahlers, and S. Baker Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany Vaccine 28 2010 4192 4203
138. S.H. Yeh, A. Gurtman, D.C. Hurley, S.L. Block, R.H. Schwartz, and S. Patterson Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers Pediatrics 126 2010 e493 e505
139. S.S. Tai Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies Crit Rev Microbiol 32 2006 139 153